NovoCure (NVCR) EBITDA Margin Growth (5y) (2019 - 2026)
NovoCure (NVCR) EBITDA Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 346.00 |
| Mar 31, 2026 | -3,867.00 |
| Dec 31, 2025 | -3,157.00 |
| Sep 30, 2025 | -3,287.00 |
| Jun 30, 2025 | -3,064.00 |
| Mar 31, 2025 | -2,111.00 |
| Dec 31, 2024 | -3,941.00 |
| Sep 30, 2024 | -2,488.00 |
| Jun 30, 2024 | -2,371.00 |
| Mar 31, 2024 | -2,163.00 |
| Dec 31, 2023 | -2,622.00 |
| Sep 30, 2023 | -3,765.00 |
| Jun 30, 2023 | -3,819.00 |
| Mar 31, 2023 | -2,499.00 |
| Dec 31, 2022 | -2,507.00 |
| Sep 30, 2022 | -698.00 |
| Jun 30, 2022 | 2,547.00 |
| Mar 31, 2022 | 3,775.00 |
| Dec 31, 2021 | 4,155.00 |
| Sep 30, 2021 | 12,401.00 |